GlassScriptPhysician profile
Hunter G Brumblay
NPI 1881716959
$60,260.46
in general payments reported to CMS, 2019-2025
7 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,415 · 2020: $8,428 · 2021: $8,645 · 2022: $7,223 · 2023: $6,117 · 2024: $7,063 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $22K · Travel and Lodging: $3,549 · Food and Beverage: $1,261 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $21,719.86 |
| Travel and Lodging | $3,549.30 |
| Food and Beverage | $1,260.53 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $56,466.44 | 2019-2025 | Si-Lok, Creo, Senza |
| Medtronic, INC. | $2,777.93 | 2023-2025 | Mazor X System, Stealthstation S8 Platform, O-Arm |
| Stryker Corporation | $405.54 | 2021-2025 | Mild Device Kit, Spinejack, N/A |
| Medtronic USA, INC. | $325.26 | 2019 | |
| Abbott Laboratories | $148.71 | 2021-2023 | Penta |
| Boston Scientific Corporation | $116.58 | 2021-2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Brumblay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.